This established the dual agonist mechanisms utility beyond weight loss and is relevant context for the broader mechanistic comparison in metabolic disease research
[11] Regulatory and Safety Field for Compounded GLP-1s in 2025 The FDA removed semaglutide from its drug shortage list in early 2025, which has direct legal consequences for 503A and 503B pharmacies that were compounding semaglutide under the shortage exemption
The mean duration of type 2 diabetes mellitus was 14 years and the mean BMI was 32 kg/m2
Ensure correct storage: Keep the pen refrigerated at 2 to 8 degrees Celsius
The most frequently encountered are 5 mg, 10 mg, 15 mg, and 30 mg vials
SURMOUNT-1 trial (NEJM) , the landmark clinical trial demonstrating tirzepatide weight loss outcomes at 5 mg, 10 mg, and 15 mg doses